Search

everythinglearnresearchcommunity

for

Search:↓

Higher levels of certain immune cells and proteins are linked to more severe lupus symptoms.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

Janus kinase inhibitors show promise for treating alopecia areata in children.

Acne patients' skin, both with and without lesions, shows a strong immune response and higher antimicrobial activity.

T-cells in alopecia areata scalp show abnormal regulation, leading to less inflammation.

Atopic dermatitis may trigger alopecia areata, and early treatment can help prevent severe cases.

Blocking interferon-gamma might help treat various autoimmune diseases.

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

Certain immune-related proteins are higher in people with alopecia and their healthy relatives, hinting at a genetic link.

Dupilumab may cause hair loss, so patients should be monitored.

Leptin affects skin and hair health and may worsen some skin conditions, but more research is needed to understand its full impact.

Scalp psoriasis inflammation is mainly caused by bacteria-related triggers.

Wnt/beta-catenin signaling in the skin helps fat cell development during hair growth and repair.

Th22 cells are essential for Tβ15-induced hair growth in mice.

Low-level laser therapy may help with hair regrowth in alopecia areata but its effectiveness for psoriasis and atopic dermatitis needs more research.

A substance called poly(I:C) increases a protein called carbonic anhydrase II in skin cells, which might help with skin defense and healing.

New targeted therapies for hair loss from alopecia areata show promise, with personalized treatment expected in the future.

Different immune responses cause hair loss in scalp diseases, with unique patterns in scalp psoriasis possibly protecting against hair loss.

People with atopic dermatitis have more CD4+ T cells that respond to a certain bacterial lipid, which may play a role in the skin condition's inflammation.

A vitamin D receptor mutation causes rickets and affects immune responses.

Higher IgE levels may play a role in alopecia areata, especially in males, children, and severe cases.

Dupilumab helped a 4-year-old grow hair back after another treatment failed.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

Naringin may help treat atopic dermatitis by reducing inflammation and improving the skin barrier.

PCOS involves immune system issues and inflammation, possibly leading to autoimmune diseases.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Reduced SIRT1 in hair cells may cause alopecia areata by triggering immune responses.

Alarmin cytokines are key in controlling skin immunity and inflammation.

Different parts of the body have unique immune characteristics in their skin.

The study was retracted.